Co-Development

Our strength lies in our robust in-house R&D infrastructure, supported by a highly qualified scientific team with deep expertise in formulation development, analytical method validation, bioequivalence study coordination, and regulatory documentation.

Savvy Pharma collaborates with local and international partners to jointly develop pharmaceutical products—from early-stage formulation to final product registration. Under this model:

• Both parties share R&D responsibilities, technical expertise, and regulatory planning.
• Costs and risks are shared proportionally.
• The resulting product IP may be jointly owned or divided by geography or therapeutic area.
• Ideal for partners seeking to reduce R&D costs while accelerating time-to-market.